相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer
Fang Ren et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones
Yi A. Ren et al.
CANCER RESEARCH (2016)
Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential
Masayo Aoki et al.
MEDIATORS OF INFLAMMATION (2016)
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
Marcin P. Iwanicki et al.
JCI INSIGHT (2016)
Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ
Huihui Wang et al.
CANCER LETTERS (2015)
Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin β4 and Akt signals
Jong-Gyu Lee et al.
SCIENTIFIC REPORTS (2015)
Tumor suppressor p53 and its gain-of-function mutants in cancer
Juan Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
Sphingosine-1-Phosphate Promotes Extravillous Trophoblast Cell Invasion by Activating MEK/ERK/MMP-2 Signaling Pathways via S1P/S1PR1 Axis Activation
Weiwei Yang et al.
PLOS ONE (2014)
Molecular Characterization of an Intact p53 Pathway Subtype in High-Grade Serous Ovarian Cancer
Takahide Hayano et al.
PLOS ONE (2014)
Cohesin in cancer: chromosome segregation and beyond
Ana Losada
NATURE REVIEWS CANCER (2014)
Sphingosine 1-Phosphate (S1P) Receptors 1 and 2 Coordinately Induce Mesenchymal Cell Migration through S1P Activation of Complementary Kinase Pathways
Patrick Quint et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
P. A. J. Muller et al.
ONCOGENE (2013)
Clinical Relevance of Gain-Of-Function Mutations of p53 in High-Grade Serous Ovarian Carcinoma
Hyo Jeong Kang et al.
PLOS ONE (2013)
Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy
Ignacio Romero et al.
ENDOCRINOLOGY (2012)
Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11
J. E. Noll et al.
ONCOGENE (2012)
Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer
Paola Tucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Mutant p53R175H upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells
I. Kogan-Sakin et al.
CELL DEATH AND DIFFERENTIATION (2011)
RAD21 Cooperates with Pluripotency Transcription Factors in the Maintenance of Embryonic Stem Cell Identity
Anja Nitzsche et al.
PLOS ONE (2011)
Unbalanced expression of sphingosine 1-phosphate receptors in diabetic nephropathy
Toshiyuki Imasawa et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2010)
A CTCF-independent role for cohesin in tissue-specific transcription
Dominic Schmidt et al.
GENOME RESEARCH (2010)
Mutant p53-induced Up-regulation of Mitogen-activated Protein Kinase Kinase 3 Contributes to Gain of Function
Aymone Gurtner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mutant p53 mediates survival of breast cancer cells
L. Y. Lim et al.
BRITISH JOURNAL OF CANCER (2009)
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Maddalena Adorno et al.
CELL (2009)
Identification of GRO1 as a Critical Determinant for Mutant p53 Gain of Function
Wensheng Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
Giulia Fontemaggi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
When mutants gain new powers: news from the mutant p53 field
Ran Brosh et al.
NATURE REVIEWS CANCER (2009)
Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations
Wensheng Yan et al.
CANCER RESEARCH (2008)
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy
Gianluca Bossi et al.
CELL CYCLE (2008)
S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells
Dongmei Wang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Mutant p53 R270H gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis
Christina Heinlein et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cohesin-dependent regulation of Runx genes
Julia A. Horsfield et al.
DEVELOPMENT (2007)
S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells
Kyoung Sun Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer
Yoko Oishi et al.
JOURNAL OF HUMAN GENETICS (2007)
SIP regulation of ovarian carcinoma invasiveness
Yoel Smicun et al.
GYNECOLOGIC ONCOLOGY (2006)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium - Regulation of synovial proliferation and inflammatory gene expression
M Kitano et al.
ARTHRITIS AND RHEUMATISM (2006)
Tumor-derived p53 mutants induce NF-κB2 gene expression
MJ Scian et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Cohesin relocation from sites of chromosomal loading to places of convergent transcription
A Lengronne et al.
NATURE (2004)
被撤回的出版物: Transactivation of the EGR1 gene contributes to mutant p53 gain of function (Retracted article. See vol. 79, pg. 2085, 2019)
L Weisz et al.
CANCER RESEARCH (2004)
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
DR Rhodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil
EN Pugacheva et al.
ONCOGENE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model
KL Murphy et al.
FASEB JOURNAL (2000)
分享论文
